Delayed addition of glucocorticoids selectively suppresses cytokine production in stimulated human whole blood.
Glucocorticoids (GC) are potent drugs proven to effectively treat inflammatory diseases, although patients typically begin therapy after the onset of symptoms. Clinical studies with cytokine inhibitors prove that these mediators drive inflammatory responses in diseases such as rheumatoid arthritis and Crohn's disease. Despite the clear sequence of cytokine-induced inflammation followed by effective GC treatment, most basic science investigations have examined the ability of GC to prevent an inflammatory response rather than halt its progression. The current studies used the Toll-like receptor 2 (TLR2) agonist palmitoyl(3)-cysteine-serine-lysine(4) (PAM) or the TLR4 agonist lipopolysaccharide (LPS) to stimulate human whole blood and determine whether postponing the addition of the GC dexamethasone (DEX) limits its ability to decrease cytokine production. Twenty-four hours after stimulation, tumor necrosis factor (TNF), interleukin-1beta (IL-1beta), IL-6, and IL-8 levels were measured, in addition to the cytokine inhibitors IL-1 soluble receptor II (SRII), IL-1 receptor antagonist, and TNF SRII. LPS rapidly induced all of the proinflammatory mediators over 24 h while failing to induce any of the cytokine inhibitors. PAM stimulation also induced IL-1beta, IL-6, and IL-8. Concomitant addition of DEX plus LPS or PAM significantly suppressed all cytokine levels. Delaying the addition of DEX until 6 h after LPS stimulation failed to decrease TNF or IL-6. In contrast, delayed DEX addition significantly suppressed PAM-induced IL-1beta, IL-6, or IL-8 and also suppressed LPS-induced IL-1beta and IL-8. Our results show that cytokines which typically increase in concentration between 6 and 24 h after stimulation were significantly suppressed by the addition of DEX 6 h after stimulation.
Horton
Devin L
DL
University of Michigan Medical School, Ann Arbor, Michigan, USA.
Remick
Daniel G
DG
D016207:Cytokines / Q000097:blood* / Q000187:drug effects*; D003907:Dexamethasone / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D008070:Lipopolysaccharides / Q000276:immunology*; D013997:Time Factors; D051195:Toll-Like Receptor 2 / Q000819:agonists* / Q000276:immunology
D016207:Cytokines; D005938:Glucocorticoids; D008070:Lipopolysaccharides; D051195:Toll-Like Receptor 2; D003907:Dexamethasone
Xenobiotica. 2009 Nov;39(11):862-70
19845437
Biochem Biophys Res Commun. 1991 Jan 15;174(1):18-24
1989598
Mol Immunol. 2002 Jan;38(8):567-80
11792425
Int J Hyg Environ Health. 2009 Sep;212(5):547-56
19395310
J Immunol. 2004 Jan 1;172(1):318-30
14688340
J Immunol. 1992 Apr 1;148(7):2133-41
1545121
Infect Immun. 2000 Jul;68(7):3965-70
10858210
J Immunol. 2006 Aug 1;177(3):1967-74
16849510
J Asthma. 2009 Sep;46(7):647-51
19728198
Lancet. 2000 Sep 23;356(9235):1099-104
11009160
J Immunol Methods. 2001 Sep 1;255(1-2):149-57
11470295
Infect Immun. 2008 Jan;76(1):189-97
17938219
N Engl J Med. 2002 Nov 14;347(20):1549-56
12432041
Cell Immunol. 2004 Sep-Oct;231(1-2):126-32
15919377
Arch Intern Med. 2008 May 26;168(10):1034-46
18504331
Shock. 2007 Aug;28(2):178-85
17529908
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000195
17636617
Mol Cell Endocrinol. 2007 Sep 15;275(1-2):30-42
17576036
Lancet. 2009 May 30;373(9678):1905-17
19482216
J Immunol Methods. 2009 Jan 30;340(2):95-101
19000693
J Allergy Clin Immunol. 1996 Jan;97(1 Pt 2):143-52
8568145
Shock. 2003 Jul;20(1):10-6
12813362
Clin Exp Allergy. 2006 Jan;36(1):122-32
16393274
Curr Opin Rheumatol. 2005 May;17(3):234-41
15838230
BMJ. 2009 Mar 16;338:b702
19289413
Infect Immun. 1995 Apr;63(4):1362-8
7890395
J Biol Chem. 1994 May 6;269(18):13289-95
8175759
Am J Pathol. 1996 Nov;149(5):1685-93
8909257
J Exp Med. 1993 Dec 1;178(6):2207-11
8245792
N Engl J Med. 2007 Dec 13;357(24):2431-40
18077808
Crit Care Med. 2009 Oct;37(10):2727-32
19885996
J Leukoc Biol. 1992 Dec;52(6):687-92
1464740
Acta Anaesthesiol Scand. 2009 Feb;53(2):183-9
19094176
J Immunol. 2005 May 15;174(10):6195-202
15879116
Cytokine. 1992 May;4(3):239-48
1498259
Am J Pathol. 1990 Nov;137(5):1173-85
2240164
Am J Pathol. 1992 May;140(5):1045-54
1533750
J Allergy Clin Immunol. 2007 Jan;119(1):115-22
17208592
Lab Invest. 1989 Jun;60(6):766-71
2733382
Am Surg. 2006 Jul;72(7):644-8
16875090